# Kindai University Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/kindai-university-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 65 |
| Citations | 144,181 |
| City | Osaka |
| Country | JP |
| Description | Kindai University Hospital is a research organisation in Osaka, JP. OpenAlex records 2,445 works and 144,181 citations for it. 630 researchers list it as their most recent affiliation. |
| Homepage | http://www.med.kindai.ac.jp/huzoku/ |
| OpenAlex ID | https://openalex.org/I4210094884 |
| Researchers | 630 |
| ROR ID | https://ror.org/00qmnd673 |
| Type | healthcare |
| Works | 2,445 |

## University papers

- [Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers](https://scholariq.org/papers/two-foxp3-cd4-t-cell-subpopulations-distinctly-control-the-prognosis-of/)
- [Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments](https://scholariq.org/papers/lactic-acid-promotes-pd-1-expression-in-regulatory-t-cells-in-highly-glycolytic/)
- [The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies](https://scholariq.org/papers/the-pd-1-expression-balance-between-effector-and-regulatory-t-cells-predicts-the/)
- [Anti-CCR4 mAb selectively depletes effector-type FoxP3 <sup>+</sup> CD4 <sup>+</sup> regulatory T cells, evoking antitumor immune responses in humans](https://scholariq.org/papers/anti-ccr4-mab-selectively-depletes-effector-type-foxp3-sup-sup-cd4-sup-sup/)
- [Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer](https://scholariq.org/papers/blockade-of-egfr-improves-responsiveness-to-pd-1-blockade-in-i-egfr-i-mutated/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.